NICE’s Changing Role: a win for NICE, if it can deliver
First in a series of articles considering the implications of NICE’s changing role for industry and patients. NICE’s role and remit has grown and morphed over its twenty plus year…
Same challenges, new opportunities – the impact for industry of the Commercial Framework for New Medicines
As any experienced market access professional will tell you, securing access to a new medicine is rarely as simple as just submitting a dossier to a national body and waiting…
Introducing Newmarket Strategy – a new consultancy specialising in healthcare innovation
Today sees the launch of Newmarket Strategy, a strategic and technical advisory business specialising in healthcare and life sciences. This new venture brings together three existing companies whose leaders have…